| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 64 |
| 1 | VEDOLIZUMAB | 37 |
| 2 | INFLIXIMAB | 23 |
| 3 | PREDNISONE | 23 |
| 4 | USTEKINUMAB | 21 |
| 5 | CARBIDOPA AND LEVODOPA | 17 |
| 6 | ACETAMINOPHEN | 14 |
| 7 | CALCIUM | 13 |
| 8 | METRONIDAZOLE | 13 |
| 9 | AZATHIOPRINE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLINDAMYCIN, BENZOYL PEROXIDE | 1 | 0.0227 |
| 1 | BISMUTH SUBGALLATE | 1 | 0.0217 |
| 2 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 3 | 0.0062 |
| 3 | USTEKINUMAB-TTWE | 1 | 0.0052 |
| 4 | TOLCAPONE | 1 | 0.0028 |
| 5 | OCTOCRYLENE, AVOBENZONE | 1 | 0.0022 |
| 6 | MOMETASONE FUROATE MONOHYDRATE | 1 | 0.0020 |
| 7 | SOLIFENACIN SUCCIATE | 3 | 0.0016 |
| 8 | DOCUSATE SODIUM 50 MG SENNOSIDES 8.6 MG | 1 | 0.0013 |
| 9 | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | 1 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 39 |
| 1 | Corticosteroid [EPC] | 36 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 31 |
| 3 | Interleukin-23 Antagonist [EPC] | 29 |
| 4 | Interleukin-12 Antagonist [EPC] | 22 |
| 5 | Proton Pump Inhibitor [EPC] | 20 |
| 6 | Aromatic Amino Acid [EPC] | 19 |
| 7 | Provitamin D2 Compound [EPC] | 15 |
| 8 | Vitamin C [EPC] | 15 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Catechol-O-Methyltransferase Inhibitor [EPC] | 7 | 0.0014 |
| 1 | GLP-2 Analog [EPC] | 9 | 0.0007 |
| 2 | Nonergot Dopamine Agonist [EPC] | 10 | 0.0006 |
| 3 | Provitamin D2 Compound [EPC] | 15 | 0.0005 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 5 | Integrin Receptor Antagonist [EPC] | 39 | 0.0004 |
| 6 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 11 | 0.0004 |
| 7 | Influenza A M2 Protein Inhibitor [EPC] | 5 | 0.0003 |
| 8 | Aromatic Amino Acid [EPC] | 19 | 0.0003 |
| 9 | Interleukin-23 Antagonist [EPC] | 29 | 0.0003 |